Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/4/14 → 6/4/20 |
Funding
- Cubist Pharmaceuticals, Inc. (Prot TR701-132)
Prot TR701-132: A Phase 3 Randomized Double-Blind Study Comparing TR-701 FA and Linezolid in Ventilated Gram-positive Nosocomial Pneumonia
- Wunderink, Richard G (PD/PI)
Project: Research project